Asthma and Fixed Airways Obstruction: Real Life Aspects.


Journal

Advances in respiratory medicine
ISSN: 2543-6031
Titre abrégé: Adv Respir Med
Pays: Switzerland
ID NLM: 101697329

Informations de publication

Date de publication:
04 Feb 2023
Historique:
received: 21 12 2022
revised: 27 01 2023
accepted: 30 01 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

We aimed to evaluate asthmatic patients with fixed airways obstruction (FAO) and to verify the impact of follow-up in an asthma-dedicated outpatient clinic on symptoms control and spirometry compared to asthmatics without FAO. We enrolled 20 asthmatic FAO+ patients and 20 FAO- asthmatics at baseline (T0) and at a one-year follow-up visit (T1). FAO+ and FAO- groups were compared for anamnesis, FEV1, asthma control test (ACT) and their ΔT0-T1. FAO+ and FAO- groups did not differ for age, BMI, pack-years, allergy, T0 blood eosinophils, comorbidities or GINA therapy step at T0 and T1, whereas, in the FAO+ group, we found more patients with a delay >5 years between symptoms onset and correct asthma diagnosis (

Identifiants

pubmed: 36825941
pii: arm91010007
doi: 10.3390/arm91010007
pmc: PMC9951872
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-73

Références

Clin Exp Allergy. 2021 Jan;51(1):39-48
pubmed: 32706916
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Breathe (Sheff). 2019 Mar;15(1):e20-e27
pubmed: 31031841
Chest. 2003 Apr;123(4):1066-72
pubmed: 12684295
Respir Med. 2015 Nov;109(11):1404-9
pubmed: 26412805
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
World Allergy Organ J. 2022 Dec 15;16(1):100727
pubmed: 36601259
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Front Physiol. 2022 May 23;13:898208
pubmed: 35677089
Front Med (Lausanne). 2020 May 21;7:191
pubmed: 32509793
Ann Am Thorac Soc. 2018 Jan;15(1):33-41
pubmed: 28910142

Auteurs

Enrico Buonamico (E)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Andrea Portacci (A)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Silvano Dragonieri (S)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Vitaliano Nicola Quaranta (VN)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Fabrizio Diaferia (F)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Elena Capozza (E)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Luigi Macchia (L)

Allergology Unit, Department "DETO", University of Bari "Aldo Moro", 70121 Bari, Italy.

Giovanna Elisiana Carpagnano (GE)

Respiratory Diseases, Department "DiBraiN", University of Bari "Aldo Moro", 70121 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH